Internal and Emergency Medicine

, Volume 8, Issue 8, pp 655–666 | Cite as

Physical activity for the prevention and treatment of metabolic disorders

  • Luca Montesi
  • Simona Moscatiello
  • Marcella Malavolti
  • Rebecca Marzocchi
  • Giulio Marchesini


Metabolic syndrome and its various features (obesity, hypertension, dyslipidemia, diabetes, and nonalcoholic fatty liver disease) are increasing worldwide and constitute a severe risk for the sustainability of the present universal Italian health care system. Lifestyle interventions should be the first therapeutic strategy to prevent/treat metabolic diseases, far before pharmacologic treatment. The role of diet and weight loss has been fully ascertained, whereas the role of physical activity is frequently overlooked both by physicians and by patients. Physical activity has favorable effects on all components of the metabolic syndrome and on the resulting cardiovascular risk, the cornerstone in the development of cardiometabolic diseases. The quantity and the frequency of physical activity necessary to produce beneficial effects has not been defined as yet, but brisk walking is considered particularly appropriate, as it can be practiced by a large number of individuals, without any additional cost, and has a low rate of injury. The effects of exercise and leisure time physical activity extend from prevention to treatment of the various components of the metabolic syndrome, as well as to mood and quality of life. Any effort should be done to favor adherence to protocols of physical activity in the community.


Diet Exercise Lifestyle Metabolic syndrome Physical activity 


  1. 1.
    Averna M, Noto D (2012) Clinical utility of novel biomarkers for cardiovascular disease risk stratification. Intern Emerg Med 7(Suppl 3):263–270CrossRefGoogle Scholar
  2. 2.
    Dagogo-Jack S, Egbuonu N, Edeoga C (2010) Principles and practice of nonpharmacological interventions to reduce cardiometabolic risk. Med Princ Pract 19:167–175PubMedCrossRefGoogle Scholar
  3. 3.
    Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA et al (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112:2735–2752PubMedCrossRefGoogle Scholar
  4. 4.
    Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA et al (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation task force on epidemiology and prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:1640–1645PubMedCrossRefGoogle Scholar
  5. 5.
    Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F et al (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364:937–952PubMedCrossRefGoogle Scholar
  6. 6.
    Flegal KM, Kit BK, Orpana H, Graubard BI (2013) Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA 309:71–82PubMedCrossRefGoogle Scholar
  7. 7.
    World Health Organization (2000) Preventing and managing the global epidemic: Report of a WHO consultation. Report No.: 894. World Health Organization, GenevaGoogle Scholar
  8. 8.
    Villareal DT, Chode S, Parimi N, Sinacore DR, Hilton T, Armamento-Villareal R et al (2011) Weight loss, exercise, or both and physical function in obese older adults. N Engl J Med 364:1218–1229PubMedCrossRefGoogle Scholar
  9. 9.
    Foster-Schubert KE, Alfano CM, Duggan CR, Xiao L, Campbell KL, Kong A et al (2012) Effect of diet and exercise, alone or combined, on weight and body composition in overweight-to-obese postmenopausal women. Obesity (Silver Spring) 20:1628–1638CrossRefGoogle Scholar
  10. 10.
    Chobanian AV (2009) Shattuck Lecture. The hypertension paradox—more uncontrolled disease despite improved therapy. N Engl J Med 361:878–887PubMedCrossRefGoogle Scholar
  11. 11.
    Sharp AS, Tapp RJ, Thom SA, Francis DP, Hughes AD, Stanton AV et al (2010) Tissue Doppler E/E’ ratio is a powerful predictor of primary cardiac events in a hypertensive population: an ASCOT substudy. Eur Heart J 31:747–752PubMedCrossRefGoogle Scholar
  12. 12.
    National Institutes of Health (1998) Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report. Obes Res 6(Suppl 2):51S–209SGoogle Scholar
  13. 13.
    Dickinson HO, Mason JM, Nicolson DJ, Campbell F, Beyer FR, Cook JV et al (2006) Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials. J Hypertens 24:215–233PubMedCrossRefGoogle Scholar
  14. 14.
    Karanja N, Lancaster KJ, Vollmer WM, Lin PH, Most MM, Ard JD et al (2007) Acceptability of sodium-reduced research diets, including the dietary approaches to stop hypertension diet, among adults with prehypertension and stage 1 hypertension. J Am Diet Assoc 107:1530–1538PubMedCrossRefGoogle Scholar
  15. 15.
    Maruthur NM, Wang NY, Appel LJ (2009) Lifestyle interventions reduce coronary heart disease risk: results from the PREMIER Trial. Circulation 119:2026–2031PubMedCrossRefGoogle Scholar
  16. 16.
    Pescatello LS, Franklin BA, Fagard R, Farquhar WB, Kelley GA, Ray CA (2004) American College of Sports Medicine position stand. Exercise and hypertension. Med Sci Sports Exerc 36:533–553PubMedCrossRefGoogle Scholar
  17. 17.
    Fagard RH, Conelissen V (2005) Physical activity, exercise, fitness and blood pressure. In: Battagay EJ, Lip GHY, Bakris GL (eds) Hypertension: principles and practice. Taylor & Francis, Boca RatonGoogle Scholar
  18. 18.
    Mora S, Redberg RF, Cui Y, Whiteman MK, Flaws JA, Sharrett AR et al (2003) Ability of exercise testing to predict cardiovascular and all-cause death in asymptomatic women: a 20-year follow-up of the lipid research clinics prevalence study. JAMA 290:1600–1607PubMedCrossRefGoogle Scholar
  19. 19.
    Church TS, Earnest CP, Skinner JS, Blair SN (2007) Effects of different doses of physical activity on cardiorespiratory fitness among sedentary, overweight or obese postmenopausal women with elevated blood pressure: a randomized controlled trial. JAMA 297:2081–2091PubMedCrossRefGoogle Scholar
  20. 20.
    Lee LL, Watson MC, Mulvaney CA, Tsai CC, Lo SF (2010) The effect of walking intervention on blood pressure control: a systematic review. Int J Nurs Stud 47:1545–1561PubMedCrossRefGoogle Scholar
  21. 21.
    Bravata DM, Smith-Spangler C, Sundaram V, Gienger AL, Lin N, Lewis R et al (2007) Using pedometers to increase physical activity and improve health: a systematic review. JAMA 298:2296–2304PubMedCrossRefGoogle Scholar
  22. 22.
    Sohn AJ, Hasnain M, Sinacore JM (2007) Impact of exercise (walking) on blood pressure levels in African American adults with newly diagnosed hypertension. Ethn Dis 17:503–507PubMedGoogle Scholar
  23. 23.
    Fossum E, Gleim GW, Kjeldsen SE, Kizer JR, Julius S, Devereux RB et al (2007) The effect of baseline physical activity on cardiovascular outcomes and new-onset diabetes in patients treated for hypertension and left ventricular hypertrophy: the LIFE study. J Intern Med 262:439–448PubMedCrossRefGoogle Scholar
  24. 24.
    Smith PJ, Blumenthal JA, Babyak MA, Craighead L, Welsh-Bohmer KA, Browndyke JN et al (2010) Effects of the dietary approaches to stop hypertension diet, exercise, and caloric restriction on neurocognition in overweight adults with high blood pressure. Hypertension 55:1331–1338PubMedCrossRefGoogle Scholar
  25. 25.
    Christmas C, Andersen RA (2000) Exercise and older patients: guidelines for the clinician. J Am Geriatr Soc 48:318–324PubMedGoogle Scholar
  26. 26.
    Madden KM, Lockhart C, Cuff D, Potter TF, Meneilly GS (2009) Short-term aerobic exercise reduces arterial stiffness in older adults with type 2 diabetes, hypertension, and hypercholesterolemia. Diabetes Care 32:1531–1535PubMedCrossRefGoogle Scholar
  27. 27.
    Cocco G, Pandolfi S (2011) Physical exercise with weight reduction lowers blood pressure and improves abnormal left ventricular relaxation in pharmacologically treated hypertensive patients. J Clin Hypertens (Greenwich) 13:23–29CrossRefGoogle Scholar
  28. 28.
    Lee LL, Arthur A, Avis M (2007) Evaluating a community-based walking intervention for hypertensive older people in Taiwan: a randomized controlled trial. Prev Med 44:160–166PubMedCrossRefGoogle Scholar
  29. 29.
    The National Cholesterol Education Program (NCEP) (2002) Expert panel on detection evaluation and treatment of high blood cholesterol in adults. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106:314–3421Google Scholar
  30. 30.
    Lee CD, Blair SN, Jackson AS (1999) Cardiorespiratory fitness, body composition, and all-cause and cardiovascular disease mortality in men. Am J Clin Nutr 69:373–380PubMedGoogle Scholar
  31. 31.
    Lakka TA, Laaksonen DE, Lakka HM, Mannikko N, Niskanen LK, Rauramaa R et al (2003) Sedentary lifestyle, poor cardiorespiratory fitness, and the metabolic syndrome. Med Sci Sports Exerc 35:1279–1286PubMedCrossRefGoogle Scholar
  32. 32.
    Kraus WE, Houmard JA, Duscha BD, Knetzger KJ, Wharton MB, McCartney JS et al (2002) Effects of the amount and intensity of exercise on plasma lipoproteins. N Engl J Med 347:1483–1492PubMedCrossRefGoogle Scholar
  33. 33.
    Kelley GA, Kelley KS, Tran ZV (2004) Walking, lipids, and lipoproteins: a meta-analysis of randomized controlled trials. Prev Med 38:651–661PubMedCrossRefGoogle Scholar
  34. 34.
    Leon AS, Sanchez OA (2001) Response of blood lipids to exercise training alone or combined with dietary intervention. Med Sci Sports Exerc 33:S502–S515 (discussion S528-509)PubMedCrossRefGoogle Scholar
  35. 35.
    Duncan GE, Anton SD, Sydeman SJ, Newton RL Jr, Corsica JA, Durning PE et al (2005) Prescribing exercise at varied levels of intensity and frequency: a randomized trial. Arch Intern Med 165:2362–2369PubMedCrossRefGoogle Scholar
  36. 36.
    Slentz CA, Houmard JA, Johnson JL, Bateman LA, Tanner CJ, McCartney JS et al (2007) Inactivity, exercise training and detraining, and plasma lipoproteins. STRRIDE: a randomized, controlled study of exercise intensity and amount. J Appl Physiol 103:432–442PubMedCrossRefGoogle Scholar
  37. 37.
    Walldius G, Jungner I (2007) Is there a better marker of cardiovascular risk than LDL cholesterol? Apolipoproteins B and A-I—new risk factors and targets for therapy. Nutr Metab Cardiovasc Dis 17:565–571PubMedCrossRefGoogle Scholar
  38. 38.
    Mora S, Lee IM, Buring JE, Ridker PM (2006) Association of physical activity and body mass index with novel and traditional cardiovascular biomarkers in women. JAMA 295:1412–1419PubMedCrossRefGoogle Scholar
  39. 39.
    Holme I, Hostmark AT, Anderssen SA (2007) ApoB but not LDL-cholesterol is reduced by exercise training in overweight healthy men. Results from the 1-year randomized Oslo Diet and Exercise Study. J Intern Med 262:235–243PubMedCrossRefGoogle Scholar
  40. 40.
    Behre C, Bergstrom G, Schmidt C (2010) Moderate physical activity is associated with lower ApoB/ApoA-I ratios independently of other risk factors in healthy, middle-aged men. Angiology 61:775–779PubMedCrossRefGoogle Scholar
  41. 41.
    Henson J, Yates T, Biddle SJ, Edwardson CL, Khunti K, Wilmot EG et al (2013) Associations of objectively measured sedentary behaviour and physical activity with markers of cardiometabolic health. Diabetologia 56:1012–1020Google Scholar
  42. 42.
    Cicero AF, D’Addato S, Santi F, Ferroni A, Borghi C (2012) Leisure-time physical activity and cardiovascular disease mortality: the Brisighella Heart Study. J Cardiovasc Med (Hagerstown) 13:559–564CrossRefGoogle Scholar
  43. 43.
    Hu FB, Sigal RJ, Rich-Edwards JW, Colditz GA, Solomon CG, Willett WC et al (1999) Walking compared with vigorous physical activity and risk of type 2 diabetes in women: a prospective study. JAMA 282:1433–1439PubMedCrossRefGoogle Scholar
  44. 44.
    Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA et al (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393–403PubMedCrossRefGoogle Scholar
  45. 45.
    Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P et al (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343–1350PubMedCrossRefGoogle Scholar
  46. 46.
    Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD, Vijay V (2006) The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia 49:289–297PubMedCrossRefGoogle Scholar
  47. 47.
    Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX et al (1997) Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 20:537–544PubMedCrossRefGoogle Scholar
  48. 48.
    Orchard TJ, Temprosa M, Barrett-Connor E, Fowler SE, Goldberg RB, Mather KJ et al (2013) Long-term effects of the diabetes prevention program interventions on cardiovascular risk factors: a report from the DPP Outcomes Study. Diabet Med 30:46–55PubMedCrossRefGoogle Scholar
  49. 49.
    Li G, Zhang P, Wang J, Gregg EW, Yang W, Gong Q et al (2008) The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet 371:1783–1789PubMedCrossRefGoogle Scholar
  50. 50.
    Lindstrom J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson JG, Hemio K et al (2006) Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet 368:1673–1679PubMedCrossRefGoogle Scholar
  51. 51.
    Knowler WC, Fowler SE, Hamman RF, Christophi CA, Hoffman HJ, Brenneman AT et al (2009) 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 374:1677–1686PubMedCrossRefGoogle Scholar
  52. 52.
    Ma J, Yank V, Xiao L, Lavori PW, Wilson SR, Rosas LG et al (2013) Translating the diabetes prevention program lifestyle intervention for weight loss into primary care: a randomized trial. Arch Intern Med 173:113–121Google Scholar
  53. 53.
    Chae JS, Kang R, Kwak JH, Paik JK, Kim OY, Kim M et al (2012) Supervised exercise program, BMI, and risk of type 2 diabetes in subjects with normal or impaired fasting glucose. Diabetes Care 35:1680–1685PubMedCrossRefGoogle Scholar
  54. 54.
    The InterAct Consortium (2012) Physical activity reduces the risk of incident type 2 diabetes in general and in abdominally lean and obese men and women: the EPIC-InterAct Study. Diabetologia 55:1944–1952CrossRefGoogle Scholar
  55. 55.
    Hallal PC, Bauman AE, Heath GW, Kohl HW 3rd, Lee IM, Pratt M (2012) Physical activity: more of the same is not enough. Lancet 380:190–191PubMedCrossRefGoogle Scholar
  56. 56.
    Jakicic JM, Jaramillo SA, Balasubramanyam A, Bancroft B, Curtis JM, Mathews A et al (2009) Effect of a lifestyle intervention on change in cardiorespiratory fitness in adults with type 2 diabetes: results from the Look AHEAD Study. Int J Obes (Lond) 33:305–316CrossRefGoogle Scholar
  57. 57.
    Wing RR (2010) Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial. Arch Intern Med 170:1566–1575PubMedGoogle Scholar
  58. 58.
    Gregg EW, Chen H, Wagenknecht LE, Clark JM, Delahanty LM, Bantle J et al (2012) Association of an intensive lifestyle intervention with remission of type 2 diabetes. JAMA 308:2489–2496PubMedCrossRefGoogle Scholar
  59. 59.
    Di Loreto C, Fanelli C, Lucidi P, Murdolo G, De Cicco A, Parlanti N et al (2005) Make your diabetic patients walk: long-term impact of different amounts of physical activity on type 2 diabetes. Diabetes Care 28:1295–1302PubMedCrossRefGoogle Scholar
  60. 60.
    Di Loreto C, Fanelli C, Lucidi P, Murdolo G, De Cicco A, Parlanti N et al (2003) Validation of a counseling strategy to promote the adoption and the maintenance of physical activity by type 2 diabetic subjects. Diabetes Care 26:404–408PubMedCrossRefGoogle Scholar
  61. 61.
    Balducci S, Zanuso S, Nicolucci A, De Feo P, Cavallo S, Cardelli P et al (2010) Effect of an intensive exercise intervention strategy on modifiable cardiovascular risk factors in subjects with type 2 diabetes mellitus: a randomized controlled trial: the Italian Diabetes and Exercise Study (IDES). Arch Intern Med 170:1794–1803PubMedCrossRefGoogle Scholar
  62. 62.
    Balducci S, Zanuso S, Cardelli P, Salvi L, Mazzitelli G, Bazuro A et al (2012) Changes in physical fitness predict improvements in modifiable cardiovascular risk factors independently of body weight loss in subjects with type 2 diabetes participating in the Italian Diabetes and Exercise Study (IDES). Diabetes Care 35:1347–1354PubMedCrossRefGoogle Scholar
  63. 63.
    Balducci S, Zanuso S, Cardelli P, Salvi L, Bazuro A, Pugliese L et al (2012) Effect of high- versus low-intensity supervised aerobic and resistance training on modifiable cardiovascular risk factors in type 2 diabetes; the Italian Diabetes and Exercise Study (IDES). PLoS ONE 7:e49297PubMedCrossRefGoogle Scholar
  64. 64.
    Bacchi E, Negri C, Zanolin ME, Milanese C, Faccioli N, Trombetta M et al (2012) Metabolic effects of aerobic training and resistance training in type 2 diabetic subjects: a randomized controlled trial (the RAED2 study). Diabetes Care 35:676–682PubMedCrossRefGoogle Scholar
  65. 65.
    Balducci S, Zanuso S, Cardelli P, Salerno G, Fallucca S, Nicolucci A et al (2012) Supervised exercise training counterbalances the adverse effects of insulin therapy in overweight/obese subjects with type 2 diabetes. Diabetes Care 35:39–41PubMedCrossRefGoogle Scholar
  66. 66.
    Ratziu V, Bellentani S, Cortez-Pinto H, Day C, Marchesini G (2010) A position statement on NAFLD/NASH based on the EASL 2009 special conference. J Hepatol 53:372–384PubMedCrossRefGoogle Scholar
  67. 67.
    Della Corte C, Alisi A, Saccari A, De Vito R, Vania A, Nobili V (2012) Nonalcoholic fatty liver in children and adolescents: an overview. J Adolesc Health 51:305–312PubMedCrossRefGoogle Scholar
  68. 68.
    Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R et al (2003) Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 37:917–923PubMedCrossRefGoogle Scholar
  69. 69.
    Marchesini G, Brizi M, Morselli-Labate AM, Bianchi G, Bugianesi E, McCullough AJ et al (1999) Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med 107:450–455PubMedCrossRefGoogle Scholar
  70. 70.
    Del Ben M, Baratta F, Polimeni L, Angelico F (2012) Non-alcoholic fatty liver disease and cardiovascular disease: epidemiological, clinical and pathophysiological evidences. Intern Emerg Med 7(suppl 3):S291–S296PubMedCrossRefGoogle Scholar
  71. 71.
    Fracanzani AL, Valenti L, Bugianesi E, Andreoletti M, Colli A, Vanni E et al (2008) Risk of severe liver disease in NAFLD with normal aminotransferase levels: a role for insulin resistance and diabetes. Hepatology 48:792–798PubMedCrossRefGoogle Scholar
  72. 72.
    Targher G, Day CP, Bonora E (2010) Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 363:1341–1350PubMedCrossRefGoogle Scholar
  73. 73.
    Calori G, Lattuada G, Ragogna F, Garancini MP, Crosignani P, Villa M et al (2011) Fatty liver index and mortality: the Cremona study in the 15th year of follow-up. Hepatology 54:145–152PubMedCrossRefGoogle Scholar
  74. 74.
    Carulli L, Ballestri S, Lonardo A, Lami F, Violi E, Losi L et al (2011) Is nonalcoholic steatohepatitis associated with a high-though-normal thyroid stimulating hormone level and lower cholesterol levels? Intern Emerg Med. doi:10.1007/s11739-011-0609-4
  75. 75.
    Marchesini G, Moscatiello S, Agostini F, Villanova N, Festi D (2011) Treatment of non-alcoholic fatty liver disease with focus on emerging drugs. Expert Opin Emerg Drugs 16:121–136PubMedCrossRefGoogle Scholar
  76. 76.
    Bae JC, Rhee EJ, Lee WY, Park SE, Park CY, Oh KW et al (2011) Combined effect of nonalcoholic fatty liver disease and impaired fasting glucose on the development of type 2 diabetes: a 4-year retrospective longitudinal study. Diabetes Care 34:727–729PubMedCrossRefGoogle Scholar
  77. 77.
    Johnson NA, Sachinwalla T, Walton DW, Smith K, Armstrong A, Thompson MW et al (2009) Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss. Hepatology 50:1105–1112PubMedCrossRefGoogle Scholar
  78. 78.
    Fealy CE, Haus JM, Solomon TP, Pagadala M, Flask CA, McCullough AJ et al (2012) Short-term exercise reduces markers of hepatocyte apoptosis in nonalcoholic fatty liver disease. J Appl Physiol 113:1–6PubMedCrossRefGoogle Scholar
  79. 79.
    Sullivan S, Kirk EP, Mittendorfer B, Patterson BW, Klein S (2012) Randomized trial of exercise effect on intrahepatic triglyceride content and lipid kinetics in nonalcoholic fatty liver disease. Hepatology 55:1738–1745PubMedCrossRefGoogle Scholar
  80. 80.
    Sreenivasa Baba C, Alexander G, Kalyani B, Pandey R, Rastogi S, Pandey A et al (2006) Effect of exercise and dietary modification on serum aminotransferase levels in patients with nonalcoholic steatohepatitis. J Gastroenterol Hepatol 21:191–198PubMedCrossRefGoogle Scholar
  81. 81.
    Johnson NA, Keating SE, George J (2012) Exercise and the liver: implications for therapy in fatty liver disorders. Semin Liver Dis 32:65–79PubMedCrossRefGoogle Scholar
  82. 82.
    St George A, Bauman A, Johnston A, Farrell G, Chey T, George J (2009) Independent effects of physical activity in patients with nonalcoholic fatty liver disease. Hepatology 50:68–76PubMedCrossRefGoogle Scholar
  83. 83.
    Promrat K, Kleiner DE, Niemeier HM, Jackvony E, Kearns M, Wands JR et al (2010) Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology 51:121–129PubMedCrossRefGoogle Scholar
  84. 84.
    van der Heijden GJ, Wang ZJ, Chu ZD, Sauer PJ, Haymond MW, Rodriguez LM et al (2010) A 12-week aerobic exercise program reduces hepatic fat accumulation and insulin resistance in obese, Hispanic adolescents. Obesity (Silver Spring) 18:384–390CrossRefGoogle Scholar
  85. 85.
    Keating SE, Hackett DA, George J, Johnson NA (2012) Exercise and non-alcoholic fatty liver disease: a systematic review and meta-analysis. J Hepatol 57:157–166PubMedCrossRefGoogle Scholar
  86. 86.
    Kistler KD, Brunt EM, Clark JM, Diehl AM, Sallis JF, Schwimmer JB (2011) Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease. Am J Gastroenterol 106:460–468 (quiz 469)PubMedCrossRefGoogle Scholar
  87. 87.
    Zelber-Sagi S, Ratziu V, Oren R (2011) Nutrition and physical activity in NAFLD: an overview of the epidemiological evidence. World J Gastroenterol 17:3377–3389PubMedCrossRefGoogle Scholar
  88. 88.
    Centis E, Moscatiello S, Bugianesi E, Bellentani S, Fracanzani AL, Calugi S et al (2013) Stage of change and motivation to healthier lifestyle in nonalcoholic fatty liver disease. J Hepatol 58:771–777Google Scholar
  89. 89.
    Gerber L, Otgonsuren M, Mishra A, Escheik C, Birerdinc A, Stepanova M et al (2012) Non-alcoholic fatty liver disease (NAFLD) is associated with low level of physical activity: a population-based study. Aliment Pharmacol Ther 36:772–781PubMedCrossRefGoogle Scholar
  90. 90.
    Krasnoff JB, Painter PL, Wallace JP, Bass NM, Merriman RB (2008) Health-related fitness and physical activity in patients with nonalcoholic fatty liver disease. Hepatology 47:1158–1166PubMedCrossRefGoogle Scholar
  91. 91.
    Newton JL, Jones DE, Henderson E, Kane L, Wilton K, Burt AD et al (2008) Fatigue in non-alcoholic fatty liver disease (NAFLD) is significant and associates with inactivity and excessive daytime sleepiness but not with liver disease severity or insulin resistance. Gut 57:807–813PubMedCrossRefGoogle Scholar
  92. 92.
    Church TS, Kuk JL, Ross R, Priest EL, Biltoft E, Blair SN (2006) Association of cardiorespiratory fitness, body mass index, and waist circumference to nonalcoholic fatty liver disease. Gastroenterology 130:2023–2030PubMedCrossRefGoogle Scholar
  93. 93.
    Garber CE, Blissmer B, Deschenes MR, Franklin BA, Lamonte MJ, Lee IM et al (2011) American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Med Sci Sports Exerc 43:1334–1359PubMedCrossRefGoogle Scholar
  94. 94.
    Frith J, Day CP, Robinson L, Elliott C, Jones DE, Newton JL (2010) Potential strategies to improve uptake of exercise interventions in non-alcoholic fatty liver disease. J Hepatol 52:112–116PubMedCrossRefGoogle Scholar
  95. 95.
    Moscatiello S, Di Luzio R, Bugianesi E, Suppini A, Hickman I, Di Domizio S et al (2011) Cognitive-behavioral treatment of non-alcoholic fatty liver disease: a propensity score-adjusted observational study. Obesity (Silver Spring) 19:763–770CrossRefGoogle Scholar
  96. 96.
    Marchesini G, Trovati M (2003) Type 2 diabetes and the Naaman syndrome. Diabetes Care 26:3195PubMedCrossRefGoogle Scholar
  97. 97.
    Heath GW, Parra DC, Sarmiento OL, Andersen LB, Owen N, Goenka S et al (2012) Evidence-based intervention in physical activity: lessons from around the world. Lancet 380:272–281PubMedCrossRefGoogle Scholar
  98. 98.
    Prochaska JO, Velicer WF (1997) The transtheoretical model of health behavior change. Am J Health Promot 12:38–48PubMedCrossRefGoogle Scholar
  99. 99.
    Dalle Grave R, Calugi S, Centis E, El Ghoch M, Marchesini G (2011) Cognitive-behavioral strategies to increase the adherence to exercise in the management of obesity. J Obes 2011:348293PubMedCrossRefGoogle Scholar
  100. 100.
    Peterson JA (2007) Get moving! Physical activity counseling in primary care. J Am Acad Nurse Pract 19:349–357PubMedCrossRefGoogle Scholar

Copyright information

© SIMI 2013

Authors and Affiliations

  • Luca Montesi
    • 1
  • Simona Moscatiello
    • 1
  • Marcella Malavolti
    • 2
  • Rebecca Marzocchi
    • 1
  • Giulio Marchesini
    • 1
    • 3
  1. 1.Unit of Metabolic Diseases and Clinical Dietetics“Alma Mater Studiorum” UniversityBolognaItaly
  2. 2.Department of Clinical and Diagnostic Medicine and Public HealthUniversity of Modena and Reggio EmiliaReggio EmiliaItaly
  3. 3.SSD of Metabolic Diseases and Clinical DieteticsS. Orsola-Malpighi Hospital, University of BolognaBolognaItaly

Personalised recommendations